Steve Beuchaw

Morgan Stanley: Illumina's Q1 Guidance Puts 2019 Targets In Question

Market, Policy Trends Are Shifting In Illumina's Favor, Morgan Stanley Says In Upgrade

4 Reasons Why Morgan Stanley Is Bullish On Myriad Genetics

Market, Policy Trends Are Shifting In Illumina's Favor, Morgan Stanley Says In Upgrade

4 Reasons Why Morgan Stanley Is Bullish On Myriad Genetics

Align Tech Faces Slowing Growth, Potential Headwinds, Morgan Stanley Says In Downgrade

Henry Schein, Patterson Companies Downgraded On Amazon Fears

Align Tech Faces Slowing Growth, Potential Headwinds, Morgan Stanley Says In Downgrade

Henry Schein, Patterson Companies Downgraded On Amazon Fears

Dentsply Sirona Is At An Attractive Entry Point For Investors Seeking Play On Structural Growth In Med-Tech

Even After Dipping Under $21, Morgan Stanley Says Myriad Genetics Is Not Cheap

Steve Beuchaw Recent News

Morgan Stanley Sees Illumina Trading At Too High A Premium To Its Peers

Cepheid Margin Expansion Unlikely To Morgan Stanley, Stays On Sidelines

Agilent's FY17 Outlook Weaker Than Expected, But Looks Beatable, Morgan Stanley Says

Morgan Stanley Downgrades Dentsply, Says 'Time For A Breather'

A Dentist's Pair Trade: Buy Dentsply, Sell Sirona Dental

Morgan Stanley Neutral On Natera, Starts At Equal-Weight

Morgan Stanley Reiterates Overweight, Raises PT On NanoString Technologies On Increased Visibility

Morgan Stanley Reiterates Equal-Weight, Lowers PT On Veracyte As Expectations Are Now Better Calibrated

Morgan Stanley Goes Over Accuray's Pros And Cons

UPDATE: Morgan Stanley Initiates Coverage On Myriad Genetics As Survey Points To Greater Share Loss

UPDATE: Morgan Stanley Reiterates On Agilent Technologies On Balanced Risk-Reward

UPDATE: Morgan Stanley Reiterates On Varian Medical Systems, Inc. As Reimbursement Change Is Coming for 2015

Morgan Stanley Has Low Expectations For Sirona Dental Systems

UPDATE: Morgan Stanley Reiterates On Varian Medical Systems On Mid-Year Updates

Morgan Stanley Believes Upside for DENTSPLY International Requires Macro Acceleration or FX Reversal

UPDATE: Morgan Stanley Reiterates on Sirona Dental Systems on EPS Acceleration Ahead

Morgan Stanley Maintains on Varian Medical Systems